JL

Jay Lichter

Venture Capitalist

Rancho Santa Fe, California

VC
Investor

Invests in

Stages:

Series A
Seed

Locations:

California

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Skills

Biotechnology
Lifesciences
Venture Capital
Pharmaceutical Industry
Mergers & Acquisitions
Entrepreneurship
Licensing
Business Development
Patents
Intellectual Property
Leadership
Management
Business Strategy
Corporate Development
Commercialization
Start-ups
Negotiation
Investments
Strategic Planning
Drug Discovery

Education

Investments

Enlaza Therapeutics

Seed

Total Funding: $160M

Arialys Therapeutics

Seed

Total Funding: $58M

Janux Therapeutics

Series A

Total Funding: $180M

AristaMD

Series A

Total Funding: $35M

Avelas Biosciences

Series A

Total Funding: $42M

Otonomy

Series A

Total Funding: $180M

Aratana Therapeutics

Series A

Total Funding: $35M

Work Experience

Avalon BioVentures

2022

  • Managing Partner

    2022

    Avalon BioVentures is a biotech venture capital firm that builds on Avalon’s 40-year success in pursuing disruptive ideas to improve life. From its established offices and labs on the Torrey Pines Mesa, in La Jolla, California, Avalon BioVentures leverages its Accelerator, which provides operational infrastructure and support, and the team’s extensive experience to identify promising science, build agile companies, and advance breakthrough therapeutics.

Arialys Therapeutics

2021

  • President and CEO

    2021

Avalon Ventures

2006

  • Managing Director

    2007

  • President and CEO

    2006 - 2008

Pacific Ridge School

2009 - 2016

  • Trustee

    2009 - 2016

Aratana Therapeutics Inc

2010 - 2015

  • Chairman Of The Board

    2010 - 2015

Afraxis, Inc

2008 - 2012

  • President and CEO

    2008 - 2012

ReVision Therapeutics, Inc.

2010 - 2011

  • President and CEO

    2010 - 2011

Carolus

2007 - 2009

  • Chairman

    2007 - 2009

Sytera

2004 - 2006

  • COO

    2004 - 2006

Sequenom

2002 - 2004

  • eVP Business Development

    2002 - 2004